港股異動 | 港交所高開2.74% 放棄向倫敦證交所提出收購要約
格隆匯10月8日丨港交所(0388.HK)高開2.74%,報232.2港元,暫成交1.1億港元,最新總市值2928.5億港元。港交所集團行政總裁李小加今日表示,決定放棄向倫敦證交所提出收購要約,因未能取得倫敦證交所管理層方面的積極迴應。並稱:“這不是一個容易的決定,放棄重大的戰略機遇固然可惜,但卻是最符合我們股東利益的決定,我們不得不忍痛放棄。未來幾年,將繼續從立足中國、連接全球和擁抱科技三個方向積極推進港交所的戰略規劃。”此前中金曾發研報指,港交所完成對倫交所要約收購的機率很低,短期經營將保持穩定,但需注意公司短期股價波動風險,維持港交所“跑贏行業”評級,目標價294港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.